Sphere Fluidics, a UK-based healthcare company, has raised £1.65m ($2.5m) in its series A round from a consortium including University of Cambridge’s Cambridge Enterprise technology commercialization fund. Other investors included investment firm 24Haymarket, non-profit Royal Society, and angel investors, including Hermann Hauser’s Providence Investment Company. Frank Craig, chief executive of Sphere Fluidics, said: “There was…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
